Cardiff Oncology, Inc.
NASDAQ:CRDF · NASDAQ Capital Market
+$0.03 today
Vol 0.93M · Avg 1.05M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-61.71%
Period High
$4.45
Period Low
$1.18
Latest
$1.21
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Forte Biosciences, Inc.
NASDAQ:FBRX
$248.90M
Innate Pharma S.A.
NASDAQ:IPHA
$170.34M
Molecular Partners AG
NASDAQ:MOLN
$147.61M
PepGen Inc.
NASDAQ:PEPG
$123.81M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$112.51M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$103.10M
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$72.53M
Cassava Sciences, Inc.
SAVA
$63.77M
Rani Therapeutics Holdings, Inc.
NASDAQ:RANI
$50.69M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest CRDF filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does CRDF have?
Intrinsic Alpha currently shows 20 recent filings for CRDF.
Explore More
Continue the stock analysis
Jump to another research area for this company.